| 1. | Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification.   |
| | Booth, Robert E. ; Campbell, Barbara K. ; Mikulich-Gilbertson, Susan K. ; Tillotson, Carrie J. ; Choi, Dongseok ; Robinson, James A. ; Calsyn, Donald A. ; Mandler, Raul N. ; Jenkins, Lindsay M. ; Thompson, Laetitia L. ; Dempsey, Catherine L. ; Liepman, Michael R. ; McCarty, Dennis |
| | AIDS and Behavior 2010 (in press). [doi: 10.1007/s10461-010-9751-7]. |
| | |
| |
| 2. | Craving Intensity and Withdrawal Severity Across Phases of Opioid Detoxification with Buprenorphine.  |
| | Chen, Hanhui ; Hillhouse, Maureen ; Doraimani, Geetha ; Hasson, Albert ; Ling, Walter |
| | Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Scottsdale, AZ, June 12-17, 2010. |
| | |
| |
| 3. | Association of Race and Ethnicity with Withdrawal Symptoms, Attrition, Opioid Use, and Side-Effects During Buprenorphine Therapy. |
| | Brown, E. Sherwood ; Tirado, Carlos F. ; Minhajuddin, Abu T. ; Hillhouse, Maureen ; Adinoff, Bryon H. ; Ling, Walter ; Doraimani, Geetha ; Thomas, Christie |
| | Journal of Ethnicity in Substance Abuse 2010;9(2):106-114. [doi: 10.1080/15332641003772587]. |
| | |
| |
| 4. | Predicting Outpatient Treatment Entry Following Detoxification for Injection Drug Use: The Impact of Patient and Program Factors. |
| | Campbell, Barbara K. ; Tillotson, Carrie J. ; Choi, Dongseok ; Bryant, Katherine ; DiCenzo, Jessica ; Provost, Scott E. ; Zammarelli, Lucy ; Booth, Robert E. ; McCarty, Dennis |
| | Journal of Substance Abuse Treatment 2010;38(suppl 1):S87-S96. [doi: 10.1016/j.jsat.2009.12.012]. |
| | |
| |
| 5. | Gender Differences at Presentation for Treatment-Seeking Opiate Dependence. |
| | Haynes, Louise F. ; Carter, Rickey E. ; Back, Sudie E. ; Payne, Rebecca ; Hillhouse, Maureen |
| | Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Reno/Sparks, Nevada, June 20-25, 2009. |
| | |
| |
| 6. | Buprenorphine Tapering Schedule and Illicit Opioid Use. |
| | Ling, Walter ; Hillhouse, Maureen ; Domier, Catherine P. ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard |
| | Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x]. |
| | |
| |
| 7. | HIV and HCV Counseling and Education (C&E) Intervention Training Manual, version 3.0.  |
| | Royer, Mark ; Fuller, Bret E. ; Ober, Allison ; Booth, Robert E. |
| | Revised for the NIDA CTN in October 2004 from: Coyle S. NIDA Counseling and Education Intervention Model (NIH Publication No. 93-3580). Bethesda, MD: National Institute on Drug Abuse, 1993.. |
| | |
| |
| 8. | Facilitating Outpatient Treatment Entry Following Detoxification for Injection Drug Use: A Multisite Test of Three Interventions. |
| | Campbell, Barbara K. ; Fuller, Bret E. ; Lee, Eun Sul ; Tillotson, Carrie ; Woelfel, Tiffany ; Jenkins, Lindsay M. ; Robinson, James A. ; Booth, Robert E. ; McCarty, Dennis |
| | Psychology of Addictive Behaviors 2009;23(2):260-270. [doi: 10.1037/a0014205]. |
| | |
| |
| 9. | Developing the Therapeutic Alliance as a Bridge to Treatment: Training Manual for the Therapeutic Alliance Intervention. |
| | Campbell, Barbara K. |
| | Unpublished manuscript. Manual developed for NIDA's National Drug Abuse Treatment Clinical Trials Network (CTN) Protocol 0017, 2008. |
| | |
| |
| 10. | HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings.  |
| | Booth, Robert E. |
| | Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, Quebec City, Canada, June 16-21, 2007. |
| | |
| |
| 11. | HIV and HCV Risk Reduction Interventions in Drug Detoxification and Treatment Settings. |
| | Booth, Robert E. |
| | Presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 17-22, 2006. |
| | |
| |
| 12. | Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join?  |
| | NIDA Center for the Clinical Trials Network (NIDA CCTN) |
| | |
| | |
| |
